Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation

Sarjukumar Panchal, Marina Serper, Therese Bittermann, Sumeet K. Asrani, David S. Goldberg, Nadim Mahmud – 23 September 2021 – Estimated glomerular filtration rate (eGFR) is adjusted for Black race in commonly used formulas. This has potential implications for access to simultaneous liver‐kidney transplantation (SLKT) as qualifying criteria rely on eGFR.

Health‐Related Quality of Life and Its Contributors According to a Preference‐Based Generic Instrument in Cirrhosis

Yangyang Hui, Nan Li, Zihan Yu, Chaoqun Li, Xiaoyu Wang, Yifan Li, Mingyu Sun, Wanting Yang, Gaoyue Guo, Xiaofei Fan, Lin Lin, Binxin Cui, Xin Chen, Bangmao Wang, Jie Zhang, Chao Sun – 23 September 2021 – It is essential to determine contributors around impairment in health‐related quality of life (HRQoL) in patients with cirrhosis aiming at improving health care and therapeutic strategy.

Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus

Ellen G. Driever, Fien A. Meijenfeldt, Jelle Adelmeijer, Robbert J. Haas, Marius C. den Heuvel, Chandrasekaran Nagasami, John W. Weisel, Constantino Fondevila, Robert J. Porte, Anabel Blasi, Nigel Heaton, Stephen Gregory, Pauline Kane, William Bernal, Yoh Zen, Ton Lisman – 23 September 2021

Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation

Sarjukumar Panchal, Marina Serper, Therese Bittermann, Sumeet K. Asrani, David S. Goldberg, Nadim Mahmud – 23 September 2021 – Estimated glomerular filtration rate (eGFR) is adjusted for Black race in commonly used formulas. This has potential implications for access to simultaneous liver‐kidney transplantation (SLKT) as qualifying criteria rely on eGFR.

HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta

Lisa Sandmann, Cihan Yurdaydin, Katja Deterding, Benjamin Heidrich, Svenja Hardtke, Patrick Lehmann, Birgit Bremer, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy, HIDIT‐II Study Group – 23 September 2021 – Standard treatment of hepatitis delta virus (HDV) infection remains pegylated‐interferon alfa (peg‐IFNα) in most centers, which is not only associated with rather low efficacy but several adverse events.

Hepatology Highlights

Chaitanya Allamneni, Ravi S. Vora, Adebowale O. Bamidele, Robert E. Schwartz, Davide Povero, David M. Salerno, Robert S. Brown, Rosa Lu Yu, Mati Ullah Dad Ullah, Daryl T.Y. Lau, Wei Zhang, Amani Lee, Enis Kostallari, Nidhi Jalan‐Sakrikar, Shalil Khanal, Enis Kostallari – 23 September 2021

Subscribe to